Ro-23-5068

N/A

Report date: 2026/03/06 20:02:51

NME

Base Information

Drug NameRo-23-5068

Drug Alias NameRo-23-5068

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics

Mechanisms of ActionBacterial DNA gyrase inhibitorsDNA topoisomerase inhibitors

TargetsBacterial DNA gyraseDNA topoisomerase

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesF. Hoffmann-La Roche Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesF. Hoffmann-La Roche Ltd

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A